{"transactions":[{"id":746048,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T22:59:33.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":250824,"source":{"system":"sec-edgar","filing":"0001193125-26-262429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000119312526262429/ownership.xml","form_type":"4"}},{"id":798756,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-28T20:26:51.000Z","date":"2026-04-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding Company stock option (\"Company Option\"), whether or not vested, and which had a per share exercise price less than the Closing Amount, was canceled and converted into the right to receive (i) a lump sum cash payment equal to (x) the excess of (a) the Closing Amount over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger, and (ii) one contractual contingent value right for each share subject to such Company Option immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding Company stock option (\"Company Option\"), whether or not vested, and which had a per share exercise price less than the Closing Amount, was canceled and converted into the right to receive (i) a lump sum cash payment equal to (x) the excess of (a) the Closing Amount over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger, and (ii) one contractual contingent value right for each share subject to such Company Option immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":63.68,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":1784},"source":{"system":"sec-edgar","filing":"0001417976-26-000002","document":"form4-04282026_080447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000141797626000002/form4-04282026_080447.xml","form_type":"4"}},{"id":798755,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-28T20:26:51.000Z","date":"2026-04-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16829,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding Company stock option (\"Company Option\"), whether or not vested, and which had a per share exercise price less than the Closing Amount, was canceled and converted into the right to receive (i) a lump sum cash payment equal to (x) the excess of (a) the Closing Amount over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger, and (ii) one contractual contingent value right for each share subject to such Company Option immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding Company stock option (\"Company Option\"), whether or not vested, and which had a per share exercise price less than the Closing Amount, was canceled and converted into the right to receive (i) a lump sum cash payment equal to (x) the excess of (a) the Closing Amount over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger, and (ii) one contractual contingent value right for each share subject to such Company Option immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":69.87,"expiration_date":"2035-03-18","underlying":"Common Stock","underlying_shares":16829},"source":{"system":"sec-edgar","filing":"0001417976-26-000002","document":"form4-04282026_080447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000141797626000002/form4-04282026_080447.xml","form_type":"4"}},{"id":798754,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-28T20:26:51.000Z","date":"2026-04-28","kind":"other","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated February 22, 2026 (the \"Merger Agreement\"), by and among Arcellx, Inc. (\"Company\"), Gilead Sciences, Inc. (\"Parent\"), and Ravens Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), the shares of common stock of Company that were tendered to Purchaser prior to the expiration time of the offer were exchanged for (x) $115.00 per share (\"Closing Amount\"), net to the seller in cash, without interest, subject to withholding tax, plus (y) one contractual contingent value right (a \"CVR\"), which represents the right to receive one contingent payment of $5.00 per CVR in cash, without interest, and subject to any withholding tax, pursuant to the terms and subject to the conditions of a contingent value rights agreement. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into Company (the \"Merger\"), with Company surviving the Merger as a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001417976-26-000002","document":"form4-04282026_080447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000141797626000002/form4-04282026_080447.xml","form_type":"4"}},{"id":1102580,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:12:30.000Z","date":"2025-06-23","kind":"sale","planned":false,"acquired":false,"shares":12407,"price":12.4346,"value":154276.0822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The range of prices for the shares of Common Stock sold is from $12.285 to $12.51. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price."}],"balance_after":241081,"source":{"system":"sec-edgar","filing":"0000950170-25-089617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000095017025089617/ownership.xml","form_type":"4"}},{"id":1117767,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T23:37:52.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":11556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":253488,"source":{"system":"sec-edgar","filing":"0000950170-25-083984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000095017025083984/ownership.xml","form_type":"4"}},{"id":1129137,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-30T20:24:21.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":1784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2022 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of May 29, 2026 or the next annual meeting of stockholders."}],"balance_after":1784,"derivative":{"exercise_price":63.68,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":1784},"source":{"system":"sec-edgar","filing":"0001415889-25-014994","document":"form4-05302025_080548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000141588925014994/form4-05302025_080548.xml","form_type":"4"}},{"id":1195580,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-20T21:15:26.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":16829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option will vest each year following the Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. \"Equity Grant Date\" shall mean March 18, 2025."}],"balance_after":16829,"derivative":{"exercise_price":69.87,"expiration_date":"2035-03-18","underlying":"Common Stock","underlying_shares":16829},"source":{"system":"sec-edgar","filing":"0001415889-25-008692","document":"form4-03202025_090323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000141588925008692/form4-03202025_090323.xml","form_type":"4"}},{"id":1325261,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-19T21:08:17.000Z","date":"2024-12-17","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.04,"expiration_date":"2024-12-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-138441","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000095017024138441/ownership.xml","form_type":"4"}},{"id":1325260,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:08:17.000Z","date":"2024-12-17","kind":"sale","planned":false,"acquired":false,"shares":14824,"price":14.56,"value":215837.44,"ownership":{"direct":true},"balance_after":241932,"source":{"system":"sec-edgar","filing":"0000950170-24-138441","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000095017024138441/ownership.xml","form_type":"4"}},{"id":1325259,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:08:17.000Z","date":"2024-12-17","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":6.04,"value":211400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total shares reported has been adjusted for 77 shares inadvertently over reported on a Form 4 filed on June 7, 2024."}],"balance_after":256756,"source":{"system":"sec-edgar","filing":"0000950170-24-138441","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000095017024138441/ownership.xml","form_type":"4"}},{"id":1486590,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T19:06:14.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":19762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2025 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":221833,"source":{"system":"sec-edgar","filing":"0000950170-24-070502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000095017024070502/ownership.xml","form_type":"4"}},{"id":1866769,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T23:50:27.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":11783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2024 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":202071,"source":{"system":"sec-edgar","filing":"0001209191-23-034665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919123034665/doc4.xml","form_type":"4"}},{"id":2244362,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:51:58.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2023 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":190288,"source":{"system":"sec-edgar","filing":"0001209191-22-034131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919122034131/doc4.xml","form_type":"4"}},{"id":2680792,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T22:30:09.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":7498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2022 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":178933,"source":{"system":"sec-edgar","filing":"0001209191-21-038371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919121038371/doc4.xml","form_type":"4"}},{"id":3118607,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-08T16:49:04.000Z","date":"2020-06-04","kind":"tax_withholding","acquired":false,"shares":2311,"price":121.53,"value":280855.83,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,491 restricted stock units."}],"balance_after":59179,"source":{"system":"sec-edgar","filing":"0001567619-20-011851","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920011851/doc1.xml","form_type":"4"}},{"id":3120187,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-05T22:59:56.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":10451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2021 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":171435,"source":{"system":"sec-edgar","filing":"0001209191-20-034841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919120034841/doc4.xml","form_type":"4"}},{"id":3232001,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-03T14:48:43.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":33394,"derivative":{"exercise_price":3.6,"expiration_date":"2021-09-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-20-005412","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920005412/doc1.xml","form_type":"4"}},{"id":3232000,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-03T14:48:43.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":8000,"price":3.6,"value":28800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":61490,"source":{"system":"sec-edgar","filing":"0001567619-20-005412","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920005412/doc1.xml","form_type":"4"}},{"id":3313274,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-10T18:59:31.000Z","date":"2020-01-08","kind":"exercise","acquired":false,"shares":17718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":63.23,"expiration_date":"2025-11-30","underlying":"Common Stock","underlying_shares":17718},"source":{"system":"sec-edgar","filing":"0001567619-20-000906","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920000906/doc1.xml","form_type":"4"}},{"id":3313273,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-10T18:59:31.000Z","date":"2020-01-08","kind":"sale","acquired":false,"shares":17718,"price":120.1087,"value":2128085.9466,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.74, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":53490,"source":{"system":"sec-edgar","filing":"0001567619-20-000906","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920000906/doc1.xml","form_type":"4"}},{"id":3313272,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-10T18:59:31.000Z","date":"2020-01-08","kind":"exercise","acquired":true,"shares":17718,"price":63.23,"value":1120309.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":71208,"source":{"system":"sec-edgar","filing":"0001567619-20-000906","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920000906/doc1.xml","form_type":"4"}},{"id":3315220,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T12:00:34.000Z","date":"2020-01-06","kind":"exercise","acquired":false,"shares":2782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":17718,"derivative":{"exercise_price":63.23,"expiration_date":"2025-11-30","underlying":"Common Stock","underlying_shares":2782},"source":{"system":"sec-edgar","filing":"0001567619-20-000740","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920000740/doc1.xml","form_type":"4"}},{"id":3315219,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-08T12:00:34.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":2782,"price":120,"value":333840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":53490,"source":{"system":"sec-edgar","filing":"0001567619-20-000740","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920000740/doc1.xml","form_type":"4"}},{"id":3315218,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-08T12:00:34.000Z","date":"2020-01-06","kind":"exercise","acquired":true,"shares":2782,"price":63.23,"value":175905.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":56272,"source":{"system":"sec-edgar","filing":"0001567619-20-000740","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920000740/doc1.xml","form_type":"4"}},{"id":3358704,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-26T16:23:30.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":20500,"derivative":{"exercise_price":63.23,"expiration_date":"2025-11-30","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-19-022263","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919022263/doc1.xml","form_type":"4"}},{"id":3358703,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-26T16:23:30.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":12000,"price":110.3928,"value":1324713.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $110 to $110.79, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":53490,"source":{"system":"sec-edgar","filing":"0001567619-19-022263","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919022263/doc1.xml","form_type":"4"}},{"id":3358702,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-26T16:23:30.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":12000,"price":63.23,"value":758760.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":65490,"source":{"system":"sec-edgar","filing":"0001567619-19-022263","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919022263/doc1.xml","form_type":"4"}},{"id":3372801,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-13T19:20:18.000Z","date":"2019-11-11","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2015 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":32500,"derivative":{"exercise_price":63.23,"expiration_date":"2025-11-30","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-19-021254","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919021254/doc1.xml","form_type":"4"}},{"id":3372800,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-13T19:20:18.000Z","date":"2019-11-11","kind":"exercise","acquired":false,"shares":6522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":14941,"derivative":{"exercise_price":18,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":6522},"source":{"system":"sec-edgar","filing":"0001567619-19-021254","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919021254/doc1.xml","form_type":"4"}},{"id":3372799,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-13T19:20:18.000Z","date":"2019-11-11","kind":"sale","acquired":false,"shares":1175,"price":104.7448,"value":123075.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.61 to $104.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":53490,"source":{"system":"sec-edgar","filing":"0001567619-19-021254","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919021254/doc1.xml","form_type":"4"}},{"id":3372798,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-13T19:20:18.000Z","date":"2019-11-11","kind":"sale","acquired":false,"shares":10345,"price":103.846,"value":1074286.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.60 to $104.51, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":54665,"source":{"system":"sec-edgar","filing":"0001567619-19-021254","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919021254/doc1.xml","form_type":"4"}},{"id":3372797,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-13T19:20:18.000Z","date":"2019-11-11","kind":"sale","acquired":false,"shares":7002,"price":103.3089,"value":723368.9178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.60 to $103.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":65010,"source":{"system":"sec-edgar","filing":"0001567619-19-021254","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919021254/doc1.xml","form_type":"4"}},{"id":3372796,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-13T19:20:18.000Z","date":"2019-11-11","kind":"exercise","acquired":true,"shares":12000,"price":63.23,"value":758760.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":72012,"source":{"system":"sec-edgar","filing":"0001567619-19-021254","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919021254/doc1.xml","form_type":"4"}},{"id":3372795,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-13T19:20:18.000Z","date":"2019-11-11","kind":"exercise","acquired":true,"shares":6522,"price":18,"value":117396.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":60012,"source":{"system":"sec-edgar","filing":"0001567619-19-021254","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919021254/doc1.xml","form_type":"4"}},{"id":3380120,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-05T18:27:45.000Z","date":"2019-11-01","kind":"tax_withholding","acquired":false,"shares":1713,"price":86.63,"value":148397.19,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 16,773 restricted stock units."}],"balance_after":53490,"source":{"system":"sec-edgar","filing":"0001567619-19-020473","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919020473/doc1.xml","form_type":"4"}},{"id":3407804,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T00:10:31.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":25000,"price":10.496,"value":262400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $10.44 to $10.61. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price."}],"balance_after":160984,"source":{"system":"sec-edgar","filing":"0001209191-19-050510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919119050510/doc4.xml","form_type":"4"}},{"id":3417481,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-11T21:09:05.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":25000,"price":12.3062,"value":307655.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $12.17 to $12.59. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price."}],"balance_after":185984,"source":{"system":"sec-edgar","filing":"0001209191-19-049200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919119049200/doc4.xml","form_type":"4"}},{"id":3459850,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-17T18:10:40.000Z","date":"2019-07-16","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":41394,"derivative":{"exercise_price":3.6,"expiration_date":"2021-09-28","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-19-014943","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919014943/doc1.xml","form_type":"4"}},{"id":3459849,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-17T18:10:40.000Z","date":"2019-07-16","kind":"exercise","acquired":true,"shares":2500,"price":3.6,"value":9000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 21,731 restricted stock units."}],"balance_after":55203,"source":{"system":"sec-edgar","filing":"0001567619-19-014943","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919014943/doc1.xml","form_type":"4"}},{"id":3465173,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-09T22:04:37.000Z","date":"2019-07-08","kind":"exercise","acquired":false,"shares":114943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.9,"expiration_date":"2019-09-16","underlying":"Common Stock","underlying_shares":114943},"source":{"system":"sec-edgar","filing":"0000899243-19-019393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000089924319019393/doc4.xml","form_type":"4"}},{"id":3465172,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-09T22:04:37.000Z","date":"2019-07-08","kind":"exercise","acquired":false,"shares":19157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.9,"expiration_date":"2019-09-16","underlying":"Common Stock","underlying_shares":19157},"source":{"system":"sec-edgar","filing":"0000899243-19-019393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000089924319019393/doc4.xml","form_type":"4"}},{"id":3465171,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-09T22:04:37.000Z","date":"2019-07-08","kind":"exercise","acquired":true,"shares":114943,"price":0.9,"value":103448.7,"ownership":{"direct":true},"balance_after":210984,"source":{"system":"sec-edgar","filing":"0000899243-19-019393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000089924319019393/doc4.xml","form_type":"4"}},{"id":3465170,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-09T22:04:37.000Z","date":"2019-07-08","kind":"exercise","acquired":true,"shares":19157,"price":0.9,"value":17241.3,"ownership":{"direct":true},"balance_after":96041,"source":{"system":"sec-edgar","filing":"0000899243-19-019393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000089924319019393/doc4.xml","form_type":"4"}},{"id":3492577,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-12T21:29:57.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":9607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2020 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":76884,"source":{"system":"sec-edgar","filing":"0001209191-19-036475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919119036475/doc4.xml","form_type":"4"}},{"id":3507466,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-30T17:39:55.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":8564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest on June 4, 2020 and the remaining 50% vest on June 4, 2021, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,731 RSUs."}],"balance_after":52703,"source":{"system":"sec-edgar","filing":"0001567619-19-012439","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919012439/doc1.xml","form_type":"4"}},{"id":3700098,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-08T11:28:27.000Z","date":"2019-01-04","kind":"exercise","acquired":false,"shares":11004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.44,"expiration_date":"2020-05-17","underlying":"Common Stock","underlying_shares":11004},"source":{"system":"sec-edgar","filing":"0001567619-19-000765","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919000765/doc1.xml","form_type":"4"}},{"id":3700097,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-08T11:28:27.000Z","date":"2019-01-04","kind":"exercise","acquired":true,"shares":11004,"price":1.44,"value":15845.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13,167 restricted stock units."}],"balance_after":44139,"source":{"system":"sec-edgar","filing":"0001567619-19-000765","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919000765/doc1.xml","form_type":"4"}},{"id":3775661,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-02T19:03:32.000Z","date":"2018-11-01","kind":"tax_withholding","acquired":false,"shares":2457,"price":49.4,"value":121375.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13,167 restricted stock units."}],"balance_after":33135,"source":{"system":"sec-edgar","filing":"0001567619-18-005040","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761918005040/doc1.xml","form_type":"4"}},{"id":3863634,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-20T18:02:29.000Z","date":"2018-07-18","kind":"exercise","acquired":false,"shares":7400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":11004,"derivative":{"exercise_price":1.44,"expiration_date":"2020-05-17","underlying":"Common Stock","underlying_shares":7400},"source":{"system":"sec-edgar","filing":"0001140361-18-033064","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118033064/doc1.xml","form_type":"4"}},{"id":3863633,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-20T18:02:29.000Z","date":"2018-07-18","kind":"exercise","acquired":true,"shares":7400,"price":1.44,"value":10656.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 18,125 restricted stock units."}],"balance_after":35592,"source":{"system":"sec-edgar","filing":"0001140361-18-033064","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118033064/doc1.xml","form_type":"4"}},{"id":3901515,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T00:39:26.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":10912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2019 annual stockholder meeting, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":67277,"source":{"system":"sec-edgar","filing":"0001209191-18-036543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919118036543/doc4.xml","form_type":"4"}},{"id":3930751,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-16T19:10:56.000Z","date":"2018-05-14","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":21463,"derivative":{"exercise_price":18,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001140361-18-024283","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118024283/doc1.xml","form_type":"4"}},{"id":3930750,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-16T19:10:56.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":7000,"price":76.137,"value":532959.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.85 to $76.64, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 18,125 restricted stock units."}],"balance_after":28192,"source":{"system":"sec-edgar","filing":"0001140361-18-024283","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118024283/doc1.xml","form_type":"4"}},{"id":3930749,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-16T19:10:56.000Z","date":"2018-05-14","kind":"exercise","acquired":true,"shares":7000,"price":18,"value":126000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 18,125 restricted stock units."}],"balance_after":35192,"source":{"system":"sec-edgar","filing":"0001140361-18-024283","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118024283/doc1.xml","form_type":"4"}},{"id":4014868,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T17:08:54.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":28463,"derivative":{"exercise_price":18,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001140361-18-012018","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118012018/doc1.xml","form_type":"4"}},{"id":4014867,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T17:08:54.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":1460,"price":80.867,"value":118065.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $80.45 to $81.21, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 18,125 restricted stock units."}],"balance_after":28192,"source":{"system":"sec-edgar","filing":"0001140361-18-012018","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118012018/doc1.xml","form_type":"4"}},{"id":4014866,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T17:08:54.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":5540,"price":79.8999,"value":442645.446,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $79.39 to $80.36, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 18,125 restricted stock units."}],"balance_after":29652,"source":{"system":"sec-edgar","filing":"0001140361-18-012018","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118012018/doc1.xml","form_type":"4"}},{"id":4014865,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T17:08:54.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":7000,"price":18,"value":126000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 18,125 restricted stock units."}],"balance_after":35192,"source":{"system":"sec-edgar","filing":"0001140361-18-012018","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118012018/doc1.xml","form_type":"4"}},{"id":4160353,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-16T16:53:09.000Z","date":"2017-11-14","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":35463,"derivative":{"exercise_price":18,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001140361-17-043114","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117043114/doc1.xml","form_type":"4"}},{"id":4160352,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-16T16:53:09.000Z","date":"2017-11-14","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 14, 2017 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":26000,"derivative":{"exercise_price":76.81,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001140361-17-043114","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117043114/doc1.xml","form_type":"4"}},{"id":4160351,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-16T16:53:09.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":7000,"price":75.1057,"value":525739.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.38, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,125 RSUs."}],"balance_after":28192,"source":{"system":"sec-edgar","filing":"0001140361-17-043114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117043114/doc1.xml","form_type":"4"}},{"id":4160350,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-16T16:53:09.000Z","date":"2017-11-14","kind":"exercise","acquired":true,"shares":7000,"price":18,"value":126000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,125 RSUs."}],"balance_after":35192,"source":{"system":"sec-edgar","filing":"0001140361-17-043114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117043114/doc1.xml","form_type":"4"}},{"id":4160349,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-16T16:53:09.000Z","date":"2017-11-14","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on November 1 of each year, beginning November 1, 2018, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,125 RSUs."}],"balance_after":28192,"source":{"system":"sec-edgar","filing":"0001140361-17-043114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117043114/doc1.xml","form_type":"4"}},{"id":4165443,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-13T11:14:30.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":18404,"derivative":{"exercise_price":1.44,"expiration_date":"2020-05-17","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001140361-17-041992","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117041992/doc1.xml","form_type":"4"}},{"id":4165442,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-13T11:14:30.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":4000,"price":1.44,"value":5760.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,125 restricted stock units."}],"balance_after":15192,"source":{"system":"sec-edgar","filing":"0001140361-17-041992","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117041992/doc1.xml","form_type":"4"}},{"id":4172700,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-03T18:17:09.000Z","date":"2017-11-01","kind":"tax_withholding","acquired":false,"shares":641,"price":88.99,"value":57042.59,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,125 restricted stock units."}],"balance_after":11192,"source":{"system":"sec-edgar","filing":"0001140361-17-041043","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117041043/doc1.xml","form_type":"4"}},{"id":4232341,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-16T11:49:02.000Z","date":"2017-08-14","kind":"exercise","acquired":false,"shares":204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":42463,"derivative":{"exercise_price":18,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":204},"source":{"system":"sec-edgar","filing":"0001140361-17-032394","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117032394/doc1.xml","form_type":"4"}},{"id":4232340,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-16T11:49:02.000Z","date":"2017-08-14","kind":"exercise","acquired":false,"shares":6144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":36286,"derivative":{"exercise_price":3.6,"expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":6144},"source":{"system":"sec-edgar","filing":"0001140361-17-032394","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117032394/doc1.xml","form_type":"4"}},{"id":4232339,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-16T11:49:02.000Z","date":"2017-08-14","kind":"exercise","acquired":false,"shares":652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":43894,"derivative":{"exercise_price":3.6,"expiration_date":"2021-09-28","underlying":"Common Stock","underlying_shares":652},"source":{"system":"sec-edgar","filing":"0001140361-17-032394","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117032394/doc1.xml","form_type":"4"}},{"id":4232338,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-16T11:49:02.000Z","date":"2017-08-14","kind":"sale","acquired":false,"shares":7000,"price":82.3132,"value":576192.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $81.94 to $82.69, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":11833,"source":{"system":"sec-edgar","filing":"0001140361-17-032394","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117032394/doc1.xml","form_type":"4"}},{"id":4232337,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-16T11:49:02.000Z","date":"2017-08-14","kind":"exercise","acquired":true,"shares":204,"price":18,"value":3672.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":18833,"source":{"system":"sec-edgar","filing":"0001140361-17-032394","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117032394/doc1.xml","form_type":"4"}},{"id":4232336,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-16T11:49:02.000Z","date":"2017-08-14","kind":"exercise","acquired":true,"shares":6144,"price":3.6,"value":22118.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":18629,"source":{"system":"sec-edgar","filing":"0001140361-17-032394","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117032394/doc1.xml","form_type":"4"}},{"id":4232335,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-16T11:49:02.000Z","date":"2017-08-14","kind":"exercise","acquired":true,"shares":652,"price":3.6,"value":2347.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":12485,"source":{"system":"sec-edgar","filing":"0001140361-17-032394","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117032394/doc1.xml","form_type":"4"}},{"id":4274472,"issuer":{"id":2473,"kind":"organization","name":"OOMA INC","symbol":"OOMA"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-23T00:14:14.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":12805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the total number of restricted stock units shall vest on the date of the Company's 2018 annual stockholder meeting to be held on or about June 20, 2018, subject to the Reporting Person's continued service as a member of the Board."}],"balance_after":56365,"source":{"system":"sec-edgar","filing":"0001209191-17-041498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417976/000120919117041498/doc4.xml","form_type":"4"}},{"id":4318207,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-16T16:54:41.000Z","date":"2017-05-15","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":44546,"derivative":{"exercise_price":3.6,"expiration_date":"2021-09-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001140361-17-021014","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117021014/doc1.xml","form_type":"4"}},{"id":4318206,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-16T16:54:41.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":1306,"price":76.4027,"value":99781.9262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $76.02 to $76.83, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":11833,"source":{"system":"sec-edgar","filing":"0001140361-17-021014","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117021014/doc1.xml","form_type":"4"}},{"id":4318205,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-16T16:54:41.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":2698,"price":75.5472,"value":203826.3456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.02 to $75.97, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":13139,"source":{"system":"sec-edgar","filing":"0001140361-17-021014","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117021014/doc1.xml","form_type":"4"}},{"id":4318204,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-16T16:54:41.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":3496,"price":74.6928,"value":261126.0288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.96 to $74.94, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":15837,"source":{"system":"sec-edgar","filing":"0001140361-17-021014","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117021014/doc1.xml","form_type":"4"}},{"id":4318203,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-16T16:54:41.000Z","date":"2017-05-15","kind":"exercise","acquired":true,"shares":7500,"price":3.6,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":19333,"source":{"system":"sec-edgar","filing":"0001140361-17-021014","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117021014/doc1.xml","form_type":"4"}},{"id":4324605,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-11T13:48:43.000Z","date":"2017-05-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":22404,"derivative":{"exercise_price":1.44,"expiration_date":"2020-05-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-17-019626","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117019626/doc1.xml","form_type":"4"}},{"id":4324604,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-11T13:48:43.000Z","date":"2017-05-09","kind":"exercise","acquired":true,"shares":5000,"price":1.44,"value":7200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":11833,"source":{"system":"sec-edgar","filing":"0001140361-17-019626","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117019626/doc1.xml","form_type":"4"}},{"id":4358118,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-05T16:32:55.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":14297,"price":95.0403,"value":1358791.1691,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $94.83 to $95.27, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,833 restricted stock units."}],"balance_after":6833,"source":{"system":"sec-edgar","filing":"0001140361-17-014934","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117014934/doc1.xml","form_type":"4"}},{"id":4358117,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-05T16:32:55.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":9166,"price":94.3235,"value":864569.201,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $93.83 to $94.79, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,833 restricted stock units."}],"balance_after":21130,"source":{"system":"sec-edgar","filing":"0001140361-17-014934","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117014934/doc1.xml","form_type":"4"}},{"id":4358116,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-05T16:32:55.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":6537,"price":93.3866,"value":610468.2042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $92.82 to $93.81, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,833 restricted stock units."}],"balance_after":30296,"source":{"system":"sec-edgar","filing":"0001140361-17-014934","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117014934/doc1.xml","form_type":"4"}},{"id":4403767,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-03T16:51:31.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":52046,"derivative":{"exercise_price":3.6,"expiration_date":"2021-09-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001140361-17-010555","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117010555/doc1.xml","form_type":"4"}},{"id":4403766,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T16:51:31.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":300,"price":95.7651,"value":28729.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.14, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":36833,"source":{"system":"sec-edgar","filing":"0001140361-17-010555","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117010555/doc1.xml","form_type":"4"}},{"id":4403765,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T16:51:31.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":7200,"price":94.9724,"value":683801.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $94.53 to $95.45, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":37133,"source":{"system":"sec-edgar","filing":"0001140361-17-010555","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117010555/doc1.xml","form_type":"4"}},{"id":4403764,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T16:51:31.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":7500,"price":3.6,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,833 restricted stock units."}],"balance_after":44333,"source":{"system":"sec-edgar","filing":"0001140361-17-010555","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036117010555/doc1.xml","form_type":"4"}},{"id":4548662,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-18T18:24:42.000Z","date":"2016-11-16","kind":"grant","acquired":true,"shares":27333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2016 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":27333,"derivative":{"exercise_price":87.62,"expiration_date":"2026-11-15","underlying":"Common Stock","underlying_shares":27333},"source":{"system":"sec-edgar","filing":"0001140361-16-087301","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087301/doc1.xml","form_type":"4"}},{"id":4548661,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-18T18:24:42.000Z","date":"2016-11-16","kind":"grant","acquired":true,"shares":6833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on November 1 of each year, beginning November 1, 2017, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,833 RSUs."}],"balance_after":36833,"source":{"system":"sec-edgar","filing":"0001140361-16-087301","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087301/doc1.xml","form_type":"4"}},{"id":4552843,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":4185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":42667,"derivative":{"exercise_price":18,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":4185},"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}},{"id":4552842,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":3315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":59546,"derivative":{"exercise_price":3.6,"expiration_date":"2021-09-28","underlying":"Common Stock","underlying_shares":3315},"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}},{"id":4552841,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":2906,"price":87.5486,"value":254416.2316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $87.27 to $87.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}},{"id":4552840,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":3734,"price":86.7546,"value":323941.6764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $86.24 to $87.13, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":32906,"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}},{"id":4552839,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":660,"price":85.7013,"value":56562.858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $85.17 to $86.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":36640,"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}},{"id":4552838,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":200,"price":84.165,"value":16833.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $84.14 to $84.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":37300,"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}},{"id":4552837,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":4185,"price":18,"value":75330.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}},{"id":4552836,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":40444,"kind":"person","name":"Galligan Andrew H","position":1,"cik":"0001417976","reported_name":"Galligan Andrew H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-16T18:26:17.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":3315,"price":3.6,"value":11934.0,"ownership":{"direct":true},"balance_after":33315,"source":{"system":"sec-edgar","filing":"0001140361-16-087000","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036116087000/doc1.xml","form_type":"4"}}]}